Nanoform Finland

0.61 EUR

+0.99 %

3,724 following

NANOFH

First North Finland

Medical Equipment & Services

Health Care

+0.99 %
+41.15 %
-27.59 %
-47.61 %
-43.04 %
-37.22 %
-71.44 %
-90.84 %
-87.84 %

Nanoform Finland operates in the medical technology sector. The company specializes in research and development of nanoparticle technology used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. Customers consist of players in the global pharmaceutical industry, with the largest operations in the Nordic market. Nanoform Finland is headquartered in Helsinki.

Read more
Market cap
52.6M EUR
Turnover
123.41K EUR
Revenue
3.55M
EBIT %
-520.56 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19.5
2026

Interim report Q1'26

20.8
2026

Interim report Q2'26

11.11
2026

Interim report Q3'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Yesterday’s release regarding the Q1 report on May 19, 2026: Invitation to Nanoform's Q1 2026 Report Presentation Here is also a link to the webcast starting at 11:00 EET: Nanoform Q1 Report 2026 With the Q1 report, there should now also be an update on the strategy for tackling ...
5/7/2026, 7:33 AM
by jerej
11
The shareholder list has been updated on the website for April. Handelsbanken has stopped its selling, and the largest seller in the top 25 appears to have been Danske Invest, which has dropped off the list. Consequently, Danske must have sold at least -700k shares.
yesterday
by jerej
8
News Powered by Cision McKinsey: Ehtiikö Suomi mukaan? Globaaleilla kasvualoilla ikkuna... McKinsey Global Instituten tuore raportti nimeää avaruuden, pelit ja bioteknologian aloiksi, joilla “The report’s analysis of Finland identifies three global growth sectors that are still in...
4/27/2026, 10:54 AM
by Latupuikko
8
Another interesting comment from the Kauppalehti forum. “I found out that Handelsbanken’s massive holding was once the responsibility of two fund portfolio managers; one bought at the IPO and the other sometime in 2024. The latter is holding roughly the current Handen (Handelsbanken...
4/17/2026, 9:39 AM
by jerej
6
It’s been the same for many years: whenever Nanoform’s price relative to its target price is mentioned in a Kauppalehti article, the share price jumps 15–20%. Today, there was another story about penny stocks where Nanoform’s upside was prominently featured at the top, just as it...
5/7/2026, 9:11 AM
by JusaVaan
5
I sold some shares today. My position here is also quite large for a micro-cap. So i used the hike to de-risk. If the share drops back to 48ct or lower i might rebuy them again. Yesterday afternoon i was wondering if some insider information got leaked, but no press release today...
5/7/2026, 12:55 PM
3
At least regarding those Handelsbanken funds that were on the sell side for months. At the turn of last month, the selling funds’ positions were at zero.
4/17/2026, 10:46 AM
by Zeta
2
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.